Gliamimic: a longitudinal, multimodal in vitro platform for evaluating glioblastoma treatment response and post-treatment tumor progression in patient-derived organoids or spheroids - Selina Camenisch; Luisa Bell; Nadine Stokar-Regenscheit; Natalia Vélez Char; Wolfram Jochum; Simon Heinze; Anna Maria Zeitlberger; Thomas Hundsberger; Marian Neidert; Peter Wick; Vanesa Ayala-Nunez (Journal of Experimental & Clinical Cancer Research, 2026)